New Advances in Topical Treatments for Chronic Hand Eczema

Chronic hand eczema (CHE) is a prevalent condition that significantly impacts patients' quality of life. Characterized by inflammation, redness, and itching, CHE can be challenging to manage and often leads to a cycle of flares and remissions. Recent advances in topical therapies have emerged as promising solutions, providing dermatologists with new options to alleviate symptoms and improve patient outcomes. The Burden of Chronic Hand Eczema CHE affects both adults and children, often resulting from a combination of genetic predisposition, environmental factors, and exposure to irritants or allergens. The condition can vary in severity and often becomes chronic, necessitating long-term treatment strategies. Unfortunately, traditional therapies such as corticosteroids and emollients may not provide adequate control for all patients, leading to a significant unmet need for effective alternatives. Recent Advances in Topical Treatments In recent years, several new topical agents have been introduced and studied for their efficacy in treating CHE. These include: Calcineurin Inhibitors: Tacrolimus and pimecrolimus, which are non-steroidal therapies, have been utilized for their ability to reduce inflammation without the side effects associated with prolonged corticosteroid use. Topical PDE4 Inhibitors: Crisaborole is a novel topical agent that inhibits phosphodiesterase 4, helping to reduce inflammation and itching. Clinical studies have shown that crisaborole can significantly improve symptoms in patients with mild to moderate eczema. JAK Inhibitors: Emerging topical Janus kinase (JAK) inhibitors, such as ruxolitinib and abrocitinib, are under investigation for their potential to treat eczema by targeting the underlying inflammatory pathways. Hydrocortisone Butyrate: This newer formulation of hydrocortisone is designed for enhanced penetration and effectiveness in treating localized areas of eczema, offering a targeted approach with a favorable safety profile. Clinical E